SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Otonomy Inc., a company that makes treatments for the middle and inner ear, announced its fourth quarter financial results on March 19, reporting a net loss of $9.8 million compared with a net loss of $7.8 million in the same quarter of the previous year.
San Diego-based Pediatric Bioscience Inc., the biotech developing blood tests for autism, has raised $1.68 million in debt financing, according to a recently amended regulatory filing.
Trovagene Inc., a developer of cell-free molecular diagnostics, announced Wednesday that Matthew L. Posard has joined the company as executive vice president and chief commercial officer.
New Jersey-based medical equipment supplier Becton, Dickinson and Company announced that it completed its acquisition of San Diego-based CareFusion Corp. for $12.2 billion.
Cidara Therapeutics Inc. has filed to raise up to $69 million in an IPO, the San Diego biotech disclosed in a registration statement filed recently.
San Diego-based Pfenex Inc., a clinical-stage biotechnology company that makes biosimilars, announced its fourth quarter financial results March 16, reporting a net loss of $3.57 million on revenue of $2.02 million. In the like quarter of 2013, the company reported $469,000 net loss on revenue of $4.23 million.
BIOTECH: Company’s Platform Matches Up Entrepreneurs With CROs
Making a drug used to fall to Big Pharma, costing a billion dollars and requiring resources and lab space to boot.
San Diego-based Trovagene Inc., a molecular diagnostics company, announced its fourth quarter financial results on March 13, reporting a net loss of $4.7 million on revenue of $56,000. In the same quarter of 2013, the company reported a net loss of $1 million on revenue of $47,000.
Nashville-based Foundations Recovery Network, a behavioral health company and integrated treatment provider, has opened a location in San Diego.
Kura Oncology Inc., a precision medicine company pursuing treatments for solid tumors and blood cancers, announced Thursday that it has raised $60 million in a private stock offering.
Independa, an integrated community engagement and remote care technologies company, announced it has closed its Series B funding round, raising $6 million.
San Diego-based Mirati Therapeutics Inc., a company developing medicines for targeted oncology, announced its fourth quarter financial results on March 11, reporting a net loss of $10.4 million. In the same quarter of 2013, the company reported a net loss of $11.2 million.
Accriva Diagnostics Holdings Inc., a hospital-based cardiovascular diagnostic company, has raised $15.5 million in equity financing according to a recent regulatory filing.
Shares of San Diego-based Acadia Pharmaceuticals Inc. rose to its highest price ever after the company canceled two investor meetings, sparking speculation that a deal to buy the drugmaker could be in the works, according to Bloomburg Business.
Mountain Health, a private, nonprofit regional community health center providing health care, health education and community services, named Arthur Blain, M.D., as its new chief medical officer.